Mirikizumab for inducing and maintaining clinical remission in ulcerative colitis.

Authors	Jordan Hindson
Journal	Nature reviews. Gastroenterology & hepatology (Nat Rev Gastroenterol Hepatol) Vol. 20 Issue 9 Pg. 559 (09 2023) ISSN: 1759-5053 [Electronic] England
PMID	37553497 (Publication Type: Journal Article)
Chemical References	mirikizumab Antibodies, Monoclonal, Humanized
Topics	Humans Colitis, Ulcerative (drug therapy) Antibodies, Monoclonal, Humanized (therapeutic use) Remission Induction

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!